Opening the Door to Better Research: A New Gateway for FSHD Scientists

By Amanda Hill
Sr. Director of Research & Care, FSHD Society

Since we launched BetterLife FSHD in August 2024, the innovative platform has provided people living with FSHD in the United States a way to track their health, get matched with clinical research opportunities, and receive personalized resources. Through structured research surveys and tools like health diaries, participants share information about their mobility, fatigue, pain, sleep, and overall well-being. This kind of input helps build a clearer picture of daily life with FSHD that goes far beyond the clinic and has the potential to dramatically impact research and therapeutic development. 

Now, researchers have a new way to learn from that lived experience. 

At the FSHD Society’s International Research Congress (IRC) on June 13 in Amsterdam, I introduced the BetterLife FSHD Research Gateway. This new portal allows qualified researchers, biotech companies, and other research organizations to access the de-identified data contributed through BetterLife, making it easier than ever to study FSHD in a real-world context. 

The Gateway arrives at a critical moment. FSHD research is gaining momentum; the IRC drew a record-breaking 300 participants this year, a reflection of how much energy and collaboration is building around the search for treatments. I was able to explain to this audience of researchers how the Gateway is designed to support a growing community of scientists by providing a resource that is both rigorous and deeply connected to the patient experience. 

With over 500 people already enrolled in BetterLife, the dataset includes insights collected at multiple points in time. This kind of longitudinal data is especially valuable for studying a disease like FSHD, which can vary widely from person to person. Scientists can explore how symptoms shift over time, examine the connections between sleep, fatigue, and mobility, or identify trends that might otherwise go unnoticed. 

The Gateway gives researchers tools to browse available data, evaluate whether it aligns with their study goals, and request access through a process that follows review by a steering committee. The data is carefully de-identified and collected in accordance with strict privacy standards. The Gateway also enables researchers to conduct studies in collaboration with BetterLife FSHD, saving time, money, and resources. 

Registries are common in rare disease research, but BetterLife is different. It’s built to give back to patients while also accelerating research through the Gateway. A patient-driven platform that connects directly with investigators to provide structured, real-time data and helps translate day-to-day experience into actionable insights, BetterLife is the kind of inventive infrastructure that can help speed the path to treatments. 

BetterLife doesn’t replace clinical trials, but it supplements information that those trials can’t always capture. It can reflect the nuance and variation of daily living with FSHD. And now, thanks to the Research Gateway, that perspective is available to researchers who are ready to listen and learn from it. 

To read the full press release, visit: New Research Portal Offers Access to Longitudinal FSHD Patient Data. You can also visit the Gateway to learn more at https://research.betterlifefshd.org/.

Each person who participates in BetterLife contributes to a clearer, more complete picture of this complex disease. As more researchers engage with the data, new insights will emerge that could lead to better studies, better questions, and, in time, better treatments. The work ahead is still challenging, but the foundation being laid today is stronger than ever.